There are 2 papers on generalized epilepsy with tonic-clonic seizures in aging research: 2 observational studies in people.
2 papers study it2 findings
See all 2 papers on generalized epilepsy with tonic-clonic seizures
“Inhibition of Niemann-Pick C1-Like 1 corresponded to a lower risk of generalized epilepsy with tonic-clonic seizures (OR = 0.98; 95% CI: 0.97-0.98; P = 1.2 × 10-34)”
- Humans2
Associations
2PCSK9 inhibitors
downin humans1OR 0.99
1 study
PCSK9 inhibitors
downin humans1OR 0.99
PCSK9 inhibitors are linked with a lower risk of generalized epilepsy with tonic-clonic seizures in humans (genetically proxied PCSK9 inhibition (Mendelian randomization)) (OR 0.99 (95% CI 0.98–1.00); P = 1.4 × 10-2).
Humansgenetically proxied PCSK9 inhibition (Mendelian randomization)
Ezetimibe
downin humans1OR 0.98
1 study
Ezetimibe
downin humans1OR 0.98
Ezetimibe is linked with a lower risk of generalized epilepsy with tonic-clonic seizures in humans (genetically proxied NPC1L1 inhibition (Mendelian randomization)) (OR 0.98 (95% CI 0.97–0.98); P = 1.2 × 10-34).
Humansgenetically proxied NPC1L1 inhibition (Mendelian randomization)